• Life science real estate is hot, with the lab space square footage growing by almost 12% across the US in the last year, according CBRE report detailing growth in the largest biotech clusters. 
  • CBRE’s report highlighted the 13 largest biotech clusters and the top 10 emerging clusters, showing how record amounts of funding from the National Insitutes of Health and venture capital are translating to the real estate markets.
  • Business Insider highlighted 6 clusters that are seeing large amounts of growth, whether they’re established but growing very rapidly, like New York City, or they’re emerging, like Pittsburgh and Houston.
  • Visit Business Insider’s homepage for more stories.

Real estate to house pharmaceutical, biotech, and other medical research professionals is growing at a rapid pace and rents continue to rise, a sign that tenant demand can support the increasing attention on life sciences from institutional investors and developers. 

Lab space has grown

Read More

The country’s cold storage capacity and cold storage real estate stock are set to grow significantly grow and could double by 2023, according to real estate consultancy CBRE.

In 2019, the storage capacity in the country was 37-39 million tonnes. Following the Covid-19 outbreak, the cold storage segment is expected to witness robust demand on the back of a surge in online grocery and fresh food sales.

CBRE South Asia, in its report, estimates the cold storage segment in India to grow steeply over the next few years on the back of a strong consumer and industrial base. Following the Covid outbreak, the demand for cold storage is also being fuelled by a wider omni-channel distribution of F&G (food and groceries) across tier I and tier II cities in the country. The cold chain network would also play a vital role in reducing the loss of produce and improving cold

Read More


CBRE Group (CBRE) is the world’s largest real estate services and investment firm by revenue. The company has leading market positions within leasing, property sales, occupier outsourcing, and valuation services. CBRE Group provides its services to real estate occupiers and investors across the globe. The company works in three segments, Advisory Services, Global Workplace Solutions, and Real Estate Investments.

Since 2010 the economy has boomed, and the real estate market has thrived. But with the COVID-19 pandemic 2020 has slowed CBRE Group’s transactions down. I believe that the current valuation is fair, and there is a possibility to have a bounce back from a V-shaped economic recovery. Nonetheless, I am not an investor right now, as I would like more of a margin of safety.

Past Financial Results

CBRE Revenue BreakdownCBRE Operating Income & Net IncomeSource: SEC 10-K’s

CBRE Group has had a revenue CAGR of 17.09% over the past five years. Now I should clear

Read More

Commercial real estate has seen its fair share of challenges since the beginning of the pandemic this year. In this article, I’m focused on CBRE Group (CBRE), which is a worldwide leader in real estate services. Since the start of the year, its shares have widely underperformed the market, with a -24% return on a YTD basis. I evaluate what makes CBRE an attractive investment at the current valuation; so let’s get started.

A Look Into CBRE Group

CBRE is a leading global real estate services company with deep insights into macro and local real estate markets. It operates with three primary lines of business. Its Advisory Services segment participates in real estate transactions, property management, and valuation services. Global Workplace Solutions helps clients with strategy, consulting, and facilities management. Lastly, its Real Estate Investments segment helps clients with project development and also acts as an investment manager. Last year,

Read More

The MarketWatch News Department was not involved in the creation of this content.

The Board of Trustees of the CBRE Clarion Global Real Estate Income Fund (NYSE: IGR) (the “Fund”) has declared a monthly distribution of $0.05 per share for the month of September 2020. The following dates apply:

IGR’s current annualized distribution rate is 9.9% based on the closing market price of $6.07 on September 8, 2020, and 8.1% based on a closing NAV of $7.42 as of the same date.

Future earnings of the Fund cannot be guaranteed, and the Fund’s distribution policy is subject to change. For more information on the Fund, please visit www.cbreclarion.com.

The Fund’s monthly distribution is set by its Board of Trustees. The Board reviews the Fund’s distribution on a quarterly basis in view of its net investment income, realized and unrealized gains, and other net unrealized appreciation or income expected during the

Read More